Sci Show: Scientists review the current evidence supporting ketamine as a therapeutic for treatment-resistant depression (TRD) and find that due to its efficacy and tolerability this psychedelic compound should be used before the 2nd generation antipsychotic drugs when treating TRD

Saturday, September 18, 2021

Scientists review the current evidence supporting ketamine as a therapeutic for treatment-resistant depression (TRD) and find that due to its efficacy and tolerability this psychedelic compound should be used before the 2nd generation antipsychotic drugs when treating TRD

https://ift.tt/2Xob7L7 via /r/science https://ift.tt/3EiHU4N

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)